By | July 16 2012 9:07 AM

GlaxoSmithKline plc (NYSE:GSK) was set to announce a $2.8 billion deal to buy biotech outfit Human Genome Sciences early Monday, several financial news outlets reported, ending a three-month pursuit of the merger.